
Médico. @digestivoHGUGM y @CEIMIHGUGM, Hospital Gregorio Marañón / IiSGM - Prof. titular, @unicomplutense - Investigador, @CIBERehd. Madrid, Spain
Joined April 2011
- Tweets10K
- Following405
- Followers2.1K
- Likes20K
Hot off the press: Recurrent primary sclerosing cholangitis after liver transplantation: impact of inflammatory bowel disease on graft outcomes in a Southern European multicenter cohort
ovid.com/10.1097/LVT.0000000…
Could a metabolite produced in the gut help protect the brain after stroke?
Zhang et al. present “Kynurenic acid mitigates post stroke brain damage through the gut-brain neural circuit” via bit.ly/3UXVvLC
This study identifies a previously unrecognised gut–brain neural circuit involving kynurenic acid (KYNA). Intestinal KYNA levels were reduced in patients with acute ischaemic stroke, and KYNA levels were associated with neurological recovery at three months in both training and validation cohorts.
In experimental stroke models, oral KYNA supplementation improved poststroke cerebral injury by activating GPR35 on enteric neurons and triggering vagal signalling. This pathway ultimately influenced brain regions including the nucleus tractus solitarius, hippocampus and hypothalamus, promoting anti-inflammatory microglial polarisation and enhancing neuronal α7 nicotinic acetylcholine receptor activity.
The findings provide striking evidence that intestinal metabolites can influence neurological recovery through a defined gut–brain neural pathway and identify KYNA–GPR35–vagus signalling as a potential therapeutic avenue for stroke recovery.
#GutBrainAxis #Microbiome
📸VI Reunión de Investigación Proyectos de GETECCU
#GETECCU26
Me gustaron mucho Jorge de León - en el papel de Des Grieux - y la orquesta dirigida por N. Luisotti (una garantía), en la Manon Lescaut que ha estrenado la temporada en el @Teatro_Real
1
150
Luis Menchén retweeted
I am very proud of my boss @Rodrigus01 for the publication of the EPOS II study in @NEJM
If our mentor, Miguel Pérez-Mateo—the person who taught us how to conduct research—knew that clinical trials would be conducted at the Gastro department in Alicante (a 300,000 inhabitants touristic city) and published in this journal, he would be very proud of the legacy he has left behind
@isabial_iis @manuelansede @GVAsanitat
Rodrigo is a good boss, a great person and an awesome researcher 🏆🏆🏆
In this planned interim analysis of a randomized trial, first surveillance colonoscopy at 5 years after the removal of high-risk adenomas was noninferior to first colonoscopy at 3 years for the incidence of colorectal cancer. Full EPoS II trial results: nej.md/4yCEnJN
Editorial: When More Is Not Better — Colonoscopy Surveillance after High-Risk Adenomas nej.md/3UXgpKK
Correspondence: Colorectal Cancer Risk among Patients with Serrated Polyps (EPoS III trial) nej.md/3UXhqCA

ALT A graph from an Original Article published in the New England Journal of Medicine article titled "Colonoscopy Intervals and Colorectal Cancer Incidence after Adenoma Removal." The graph shows the cumulative incidence of colorectal cancer in the two trial groups. The trial name, EPoS II, is in parentheses after the title. The NEJM identity sits at the bottom.
Estupendo artículo de Andrés Trapiello reivindicando a José Antonio Muñoz Rojas. abc.es/cultura/cultural/camp…
“Lo cierto es que en aquella época los rituales estaban al servicio de la vida…” Qué maravilla de ensayo, muchas gracias, @MAecocardio.
Luis Menchén retweeted
Acabar con los exámenes de septiembre ha sido un crimen educativo. De todas las mutilaciones a la escuela para maquillar el fracaso escolar, esta ha sido la más cobarde. 🧵va...
Luis Menchén retweeted
🧵 New multicenter study (@GETECCU, 211 patients, 43 Spanish hospitals) on severe immune checkpoint inhibitor colitis (IMC), just out in @DDS_Journal.
Only 50.2% of patients responded to IV corticosteroids. What predicts failure? 👇
Me ha encantado. Y estoy convencido de que le encantará a todos los entusiastas, como yo, de esa maravilla de país que es Portugal.

























